Correction: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial

graphical errors in our tables and in the labelling of Figure 3. Th ere have been no changes to the results or their interpretation. In Tables 1, 2 and 3 the number of dexmedetomidine patients without sepsis should read 21 instead of the published 20. Th e numbers in the corresponding text are correct. Th e corrected tables can be found overleaf. In Figure 3, in the “Patients at risk” table below the Kaplan-Meier curve, the dexmedetomidine and lorazepam labels are incorrect. Th e top row should be labeled lorazepam and the bottom row should be labeled dexmedetomidine. Th e corrected fi gure can be found overleaf.